Literature DB >> 16251810

Peripheral neuropathies associated with HIV and hepatitis C co-infection: a review.

Lydia B Estanislao1, Susan Morgello, David M Simpson.   

Abstract

Co-infection with HIV and hepatitis C has become increasingly prevalent. It is a major source of morbidity in HIV-infected populations. Distal symmetric polyneuropathy is the most common form of peripheral neuropathy in HIV as well as hepatitis C mono-infection. There is considerable overlap in the symptoms and signs of HIV and hepatitis C neuropathy. It is not known whether there are additive or synergistic effects on the peripheral nerve by these two viruses. There is a need for studies to further elucidate the mechanisms involved.

Entities:  

Mesh:

Year:  2005        PMID: 16251810     DOI: 10.1097/01.aids.0000192082.41561.49

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.

Authors:  Ronald J Ellis; Debralee Rosario; David B Clifford; Justin C McArthur; David Simpson; Terry Alexander; Benjamin B Gelman; Florin Vaida; Ann Collier; Christina M Marra; Beau Ances; J Hampton Atkinson; Robert H Dworkin; Susan Morgello; Igor Grant
Journal:  Arch Neurol       Date:  2010-05

2.  Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV.

Authors:  C L Cherry; J S Affandi; B J Brew; J Creighton; S Djauzi; D J Hooker; D Imran; A Kamarulzaman; P Kamerman; J C McArthur; R D Moore; P Price; K Smyth; I L Tan; S Vanar; A Wadley; S L Wesselingh; E Yunihastuti
Journal:  Neurology       Date:  2010-05-11       Impact factor: 9.910

3.  The Symptom Experience of HIV/HCV-Coinfected Adults.

Authors:  Carol Bova; Carol Jaffarian; Pauline Himlan; Linda Mangini; Lisa Ogawa
Journal:  J Assoc Nurses AIDS Care       Date:  2008 May-Jun       Impact factor: 1.354

4.  Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy.

Authors:  Jemily Malvar; Florin Vaida; Chelsea Fitzsimons Sanders; J Hampton Atkinson; William Bohannon; John Keltner; Jessica Robinson-Papp; David M Simpson; Christina M Marra; David B Clifford; Benjamin Gelman; Juanjuan Fan; Igor Grant; Ronald J Ellis
Journal:  Pain       Date:  2015-04       Impact factor: 7.926

5.  Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barré syndrome.

Authors:  Lourdes Mateos-Hernández; Margarita Villar; Ernesto Doncel-Pérez; Marco Trevisan-Herraz; Ángel García-Forcada; Francisco Romero Ganuza; Jesús Vázquez; José de la Fuente
Journal:  Oncotarget       Date:  2016-11-15

Review 6.  Understanding the etiology and management of HIV-associated peripheral neuropathy.

Authors:  Kara Stavros; David M Simpson
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.495

Review 7.  Could Proteomics Become a Future Useful Tool to Shed Light on the Mechanisms of Rare Neurodegenerative Disorders?

Authors:  Maddalena Cagnone; Anna Bardoni; Paolo Iadarola; Simona Viglio
Journal:  High Throughput       Date:  2018-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.